GlassScriptPhysician profile
Jeffrey Thormeyer
NPI 1043421274
$4,144.03
in general payments reported to CMS, 2019-2025
12 companies · $84.99 in 2025
The $84.99 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $546 · 2021: $172 · 2022: $63.02 · 2023: $80.42 · 2024: $2,329 · 2025: $84.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,786 · Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,785.88 |
| Food and Beverage | $708.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,660.33 | 2019-2025 | Mako, Gamma, T2 |
| Wardlow Enterprises | $1,212.33 | 2019-2020 | |
| Pacira Therapeutics, INC. | $55.54 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $39.42 | 2019-2023 | |
| Amgen INC. | $36.65 | 2019-2020 | |
| Ebi, LLC | $28.86 | 2025 | Biomet Ebi Bone Healing System |
| Zimvie INC. | $28.44 | 2022 | |
| Zimmer Biomet Holdings, INC. | $22.75 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $17.51 | 2021 | |
| Smith+Nephew, INC. | $16.94 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $13.18 | 2023 | Exparel, Iovera, Zilretta |
| Medtronic, INC. | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Thormeyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.